`
`New Page 1
`
`http://w w w .fda.gov/ohrms/dockets/ac/cder01.htm
`
`Go
`
`99 captures
`24 Jan 01 - 12 Jul 12
`
`APR
`
`JUN OCT
`
`17
`
`2000
`
`2001
`
`2002
`
`[ Federal Registers ] [ FDA Home Page ][Dockets Home Page][CBER][CDRH][OC][Up]
`
`
`
`CDER 2001 Meeting Documents
`
`Anti-Infective Drugs Advisory Committee
`Transcript Text ID
`Minutes
`(size in kb)
`(size in kb)
`3746t1.rtf (388) & html
`(392)
`
`
`
`Transcript PDF ID
`Day
`(size in kb)
`4/26 Pages 1- 100
`3746t1_01.pdf
`(10,540)
`
`Start
`4/26
`
`Pages 101-200
`3746t1_02.pdf
`(10,646)
`
`Pages 201-339
`3746t1_03.pdf
`(19,170)
`
`4/23
`
`4/23
`
`3744t1_01.pdf & htm
`
`3744t1.rtf
`
`
`
`4/24
`
`3744t2.pdf & htm
`
`3744t2.rtf
`
`
`
`
`
`Other Docs ID
`Agenda
`3746a1.pdf, htm
`
`Briefing Info.
`3746b1.htm
`
`Roster
`3746r1_01committee.pdf,
`htm
`3746r1_02quest.pdf, htm
`
`Slides
`3746s1.htm
`Notice of Mtg.
`032301d.htm & pdf
`
`Briefing Information
`3744b1.htm
`
`Agenda
`3744a1.pdf, htm
`
`Roster
`3744r1.pdf, htm
`
`Questions
`3744q1.pdf, htm
`
`Slides
`3744s1.pdf
`Briefing Information
`3744b2.htm
`
`Agenda
`3744a2.pdf, htm
`
`Roster
`3744r2.pdf, htm
`
`Questions
`
`https://web.archive.org/web/20010617210030/http://www.fda.gov/ohrms/dockets/ac/cder01.htm
`
`1/7
`
`Wockhardt 1018
`
`
`
`5/13/2014
`
`New Page 1
`
`01/30
`
`01/30 3719t1_01.pdf (6126)
`3719t1_02.pdf (6374)
`3719t1_03.pdf (6385)
`3719t1_04.pdf (6428)
`
`3719t1.rtf (439)
`
`3719m1.doc, pdf
`
`[ Top ]
`
`Start
`2/27
`
`Day
`2/27
`
`Transcript PDF ID
`(size in kb)
`3731t1_01.pdf (6394)
`3731t1_02.pdf (6275)
`3731t1_03.pdf (3920)
`
`Anti-Viral Drugs Advisory Committee
`Transcript Text ID
`Minutes
`(size in kb)
`(size in kb)
`3731t1.rtf (271)
`
`
`
`1/10
`
`1/10
`
`3676t1_a.pdf
`3676t1_b.pdf
`3676t1_c.pdf
`3676t1_d.pdf
`
`3676t1.rtf
`
`
`
`1/11
`
`3678t1_a.pdf
`3678t1_b.pdf
`3678t1_c.pdf
`
`3578t1.rtf
`
`
`
`
`
`3744q2.pdf, htm
`
`Slides
`3744s2.pdf
`Briefing Package
`3719b1.htm
`
`Roster
`3719r1.htm
`
`Slides
`3719s1.htm
`
`Agenda
`3719a1.htm
`
`Question
`3719q1.htm
`
`Other Docs ID
`Agenda
`3731a1.doc, pdf
`
`Slides
`3731s1.htm
`
`Roster
`3731r1.doc, pdf
`3731r2.doc, pdf
`
`Briefing Information
`3731b1.htm
`
`Questions
`3731q1.doc, pdf
`Agenda
`3676a1.doc, pdf
`
`Roster
`3676r1.doc, pdf
`
`Briefing Information
`3676b1.htm
`
`Slides
`3676s1.htm
`3676s1_03.pdf
`
`Agenda
`3678a1.doc, pdf
`
`https://web.archive.org/web/20010617210030/http://www.fda.gov/ohrms/dockets/ac/cder01.htm
`
`2/7
`
`Wockhardt 1018
`
`
`
`5/13/2014
`
`New Page 1
`
`3678t1_d.pdf
`
`[ Top ]
`
`Start
`4/19
`
`Day
`4/20
`
`Transcript PDF ID
`(size in kb)
`3740t1_01.pdf
`3740t1_02.pdf
`3740t1_03.pdf
`
`Arthritis Advisory Committee
`Transcript Text ID
`(size in kb)
`3740t1.rtf
`
`
`
`Minutes
`(size in kb)
`
`2/7
`
`2/7
`
`3677t1_01.pdf (6421)
`3677t1_02.pdf (6733)
`3677t1_03.pdf (2448)
`
`3677t1.rtf (561)
`
`
`
`02/08 3677t2_01.pdf (6774)
`3677t2_02.pdf (6852)
`3677t2_03.pdf (2918)
`
`3677t2.rtf (597)
`
`
`
`
`
`Briefing Information
`3678b1.htm
`
`Slides
`3678s1.htm
`
`Other Docs ID
`Agenda
`3740a1.htm & pdf
`
`Briefing Information
`3740b1.htm
`
`Questions
`3740q1.htm & pdf
`
`Roster
`3740r1_01 htm & pdf
`3740r1_02 htm & pdf
`
`Slides
`3740s1.htm
`Agenda
`3677a1.doc, pdf
`
`Roster
`3677r1_01.doc, pdf
`
`Guest Roster
`3677r1_02.doc, pdf
`
`Briefing Information
`3677b1.htm
`
`Questions
`3677q1.doc, pdf
`
`Slides
`3677s1.htm
`
`Briefing Package
`3677b2.htm
`
`Agenda
`3677a2.doc & pdf
`
`Questions
`3677q2_01.doc & pdf
`3677q2_02.doc & pdf
`
`Slides
`3677s2.htm
`
`https://web.archive.org/web/20010617210030/http://www.fda.gov/ohrms/dockets/ac/cder01.htm
`
`3/7
`
`Wockhardt 1018
`
`
`
`New Page 1
`
`Cardiovascular and Renal Drugs Advisory Committee
`Transcript PDF ID
`Transcript Text ID
`Minutes
`(size in kb)
`(size in kb)
`(size in kb)
`
`
`
`
`
`
`
`
`
`5/13/2014
`
`[ Top ]
`
`Start
`5/24
`
`Day
`5/24
`
`
`
`
`
`5/25
`
`
`
`[ Top ]
`
`Start
`05/11
`
`Day
`05/11
`
`Nonprescription Drugs Advisory Committee
`Transcript PDF ID
`Transcript Text ID
`Minutes
`(size in kb)
`(size in kb)
`(size in kb)
`
`
`
`
`
`[ Top ]
`
`Start
`06/07
`
`Day
`06/07
`
`Transcript PDF ID
`(size in kb)
`
`Oncologic Drugs Advisory Committee
`Transcript Text ID
`Minutes
`(size in kb)
`(size in kb)
`
`
`
`Other Docs ID
`Briefing Information
`3749b1.htm
`
`Agenda
`3749a1.pdf & htm
`
`Questions
`3749q1.pdf & htm
`Briefing Information
`3749b2.htm
`
`Questions
`3749q2.pdf & htm
`
`Other Docs ID
`Agenda
`3737a1.htm, pdf
`
`Planning Agenda
`3737a1_planning.htm,
`
`Questions
`3737q1.htm, pdf
`
`Briefing Information
`3737b1.htm
`Petition
`
`Other Docs ID
`Agenda
`3757a1.htm & pdf
`
`Questions
`3757q1.htm & pdf
`
`Briefing Information
`3757b1.htm & pdf
`Agenda
`3743a1.htm & pdf
`
`
`
`
`
`4/24
`
`4/24
`
`3743t1_01.pdf
`3743t1_02.pdf
`
`3743t1.rtf
`
`https://web.archive.org/web/20010617210030/http://www.fda.gov/ohrms/dockets/ac/cder01.htm
`
`4/7
`
`Wockhardt 1018
`
`
`
`3743t1_03.pdf
`
`New Page 1
`
`Briefing Information
`3743b1.htm & pdf
`
`5/13/2014
`
`[ Top ]
`
`Start
`6/6
`
`Day
`6/6
`
`
`
`Peripheral & Central Nervous System Drugs Advisory Committee
`Transcript PDF ID
`Transcript Text ID
`Minutes
`(size in kb)
`(size in kb)
`(size in kb)
`
`
`
`
`
`3/13
`
`3/13
`
`3724t1.pdf
`
`3724t1.rtf
`
`3724m1.htm
`3742m1.pdf
`
`
`
`3/14
`
`3724t2.pdf
`
`3724t2.rtf
`
`3724m2.htm
`3724m2.pdf
`
`Other Docs ID
`Agenda
`3754a1.pdf, html
`
`Rosters
`Members 3754r1_01.pdf,
`html
`
`Consultants
`3754r1_02.pdf, html
`
`Public Hearing
`3754r1_03.pdf, html
`
`Questions
`3754q1.pdf, html
`
`Briefing Information
`3754b1.htm
`Agenda
`3724a1.doc, pdf
`
`Roster
`3724r1_01.doc, pdf
`
`Briefing Info
`3724b1.htm
`
`Slides
`3724s1.htm
`Agenda (DRAFT)
`3724a2.doc, pdf
`
`Roster
`3724r1_02.doc, pdf
`
`Briefing Info
`3724b2.htm
`
`Slides
`3724s2.htm
`
`[ Top ]
`
`Pharmaceutical Science Drugs Advisory Committee
`Transcript PDF ID
`Transcript Text ID
`Minutes
`(size in kb)
`(size in kb)
`(size in kb)
`
`Start
`
`Day
`
`https://web.archive.org/web/20010617210030/http://www.fda.gov/ohrms/dockets/ac/cder01.htm
`
`Other Docs ID
`
`5/7
`
`Wockhardt 1018
`
`
`
`5/13/2014
`
`5/3
`
`5/3
`
`3742t1.pdf
`(10,036)
`
`New Page 1
`Non-Clinical Studies Subcommittee
`3742t1.rtf (93)& html
`
`(100 )
`
`[ Top ]
`
`Psychopharmacologic Drugs Advisory Committee
`Transcript PDF ID
`Transcript Text ID
`Minutes
`(size in kb)
`(size in kb)
`(size in kb)
`3685t1.pdf, txt
`3685m1.pdf
`
`
`
`Start
`2/14
`
`Day
`2/14
`
`
`
`2/15
`
`3685t2.pdf, txt
`
`
`
`3685m2.pdf
`
`[ Top ]
`
`Start
`05/11
`
`Day
`05/11
`
`Pulmonary-Allergy Drugs Advisory Committee
`Transcript PDF ID
`Transcript Text ID
`Minutes
`(size in kb)
`(size in kb)
`(size in kb)
`
`
`
`
`
`Agenda
`3742a1.htm & pdf
`
`Roster
`3742r1.htm & pdf
`3742r2.htm & pdf
`
`Briefing Info
`3742b1.htm & pdf
`
`Notice of Meeting
`98frx032301g.htm
`98frx032301g.pdf
`
`Other Docs ID
`Agenda
`3685a1.doc, pdf
`
`Roster
`3685r1.doc, pdf
`
`Questions
`3685q1.doc, pdf
`
`Briefing Info
`3685b1.htm
`
`Slides
`3685s.htm
`Agenda
`3685a2.doc, pdf
`
`Roster
`3685r2.doc, pdf
`
`Questions
`3685q2.doc, pdf
`
`Briefing Info
`3685b2.htm
`
`Other Docs ID
`Agenda
`3737a1.htm, pdf
`
`https://web.archive.org/web/20010617210030/http://www.fda.gov/ohrms/dockets/ac/cder01.htm
`
`6/7
`
`Wockhardt 1018
`
`
`
`Planning Agenda
`3737a1_planning.htm,
`
`Questions
`3737q1.htm, pdf
`
`Briefing Information
`3737b1.htm
`Petition
`
`5/13/2014
`
`New Page 1
`
`
`
`https://web.archive.org/web/20010617210030/http://www.fda.gov/ohrms/dockets/ac/cder01.htm
`
`7/7
`
`Wockhardt 1018